News & Events

Dispatches from the world of RMPs: Accent news and events

What’s "c/λ" at Accent?

October 18, 2021 Ipsen adds another program into its pre-clinical R&D Oncology pipeline through an exclusive worldwide collaboration with Accent Therapeutics, targeting the RNA modifying protein, METTL3

September 28, 2020 Fierce Biotech names Accent Therapeutics as one of its “Fierce 15” Biotech Companies of 2020

March 15-16, 2022

2022 Fierce BD&L Summit for Life Sciences

Our SVP of Business Development & Portfolio Strategy, David Brower, participates in the panel "Choosing the Right Business Partner that Aligns with the Company's Goals" at the 2022 Fierce BD&L Summit for Life Sciences, March 15